These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemotherapy of inoperable bronchogenic carcinoma. Behera D; Malik SK Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850 [No Abstract] [Full Text] [Related]
4. Hexamethylmelamine in inoperable bronchogenic carcinoma. Takita H N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448 [No Abstract] [Full Text] [Related]
5. [Prognostic factors in the chemotherapy of bronchial cancers]. Alberto P Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755 [No Abstract] [Full Text] [Related]
6. [Cytostatic therapy of tumors of the lung]. De Marco F; Saviano G; Tenore G Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917 [No Abstract] [Full Text] [Related]
7. Combination chemotherapy of advanced non-oat cell carcinoma of the lung. Richards F; White DR; Muss HB; Jackson DV; Stuart JJ; Cooper MR; Rhyne L; Spurr CL Cancer; 1979 Nov; 44(5):1576-81. PubMed ID: 227571 [No Abstract] [Full Text] [Related]
8. [Does chemotherapy bring real benefit to patients with inoperable bronchial epidermoid cancer?]. Depierre A Rev Mal Respir; 1986; 3(4):169-71. PubMed ID: 3786923 [No Abstract] [Full Text] [Related]
9. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma. Takita H; Brugarolas A; Mittelman A; Vincent R Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743 [No Abstract] [Full Text] [Related]
10. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report. Tate CF; Viamonte M; Agnew JR Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229 [No Abstract] [Full Text] [Related]
12. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)]. Klastersky J; Sculier JP Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462 [No Abstract] [Full Text] [Related]
13. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer. Pacilio G; Puzziello T Bronches; 1971; 21(4):402. PubMed ID: 4340778 [No Abstract] [Full Text] [Related]
15. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung. Gottlieb JA; Serpick AA Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626 [No Abstract] [Full Text] [Related]
16. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease. Mountain CF Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081 [No Abstract] [Full Text] [Related]
17. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma. Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR. Perevodchikova NI; Bychkov MB Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645 [No Abstract] [Full Text] [Related]
20. [Bronchial arteriography and intraarterial chemotherapy in bronchogenic carcinoma (author's transl)]. Hellekant C Radiologe; 1979 Dec; 19(12):521-7. PubMed ID: 229511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]